{"entity":{"type":"insider","cik":"0001738885","url":"/insider/0001738885","json_url":"/insider/0001738885.json","name":"Bodmer Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2023-05-10","last":"2023-11-08","span_basis":"filed_date"},"name_variants":[{"name":"Bodmer Mark","source":"filing","n_filings":5,"first_seen":"2023-05-10","last_seen":"2023-11-08"}],"transactions":[{"id":8489047,"accession":"0001694665-23-000179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001694665-23-000179","line_url":"/filing/0001694665-23-000179#line-2","is_derivative":false,"issuer_cik":"0001694665","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001694665","owner_cik":"0001738885","owner_name":"Bodmer Mark","owner_display_name":"Bodmer Mark","owner_url":"/insider/0001738885","role":"Officer (CSO, President of R&D)","role_mark":"O","role_mark_label":"Officer (CSO, President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3163.0,"shares_display":"3,163","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":1043.79,"total_display":"1,043.79","total_whole":"1,044","shares_owned_after":25732.0,"shares_owned_after_display":"25,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-08","filed_date":"2023-11-08","scope":"insider"},{"id":8565076,"accession":"0001694665-23-000169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001694665-23-000169","line_url":"/filing/0001694665-23-000169#line-2","is_derivative":false,"issuer_cik":"0001694665","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001694665","owner_cik":"0001738885","owner_name":"Bodmer Mark","owner_display_name":"Bodmer Mark","owner_url":"/insider/0001738885","role":"Officer (CSO, President of R&D)","role_mark":"O","role_mark_label":"Officer (CSO, President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6854.0,"shares_display":"6,854","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":2261.82,"total_display":"2,261.82","total_whole":"2,262","shares_owned_after":22270.0,"shares_owned_after_display":"22,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-03","scope":"insider"},{"id":8489039,"accession":"0001694665-23-000136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001694665-23-000136","line_url":"/filing/0001694665-23-000136#line-2","is_derivative":false,"issuer_cik":"0001694665","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001694665","owner_cik":"0001738885","owner_name":"Bodmer Mark","owner_display_name":"Bodmer Mark","owner_url":"/insider/0001738885","role":"Officer (CSO, President of R&D)","role_mark":"O","role_mark_label":"Officer (CSO, President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3128.0,"shares_display":"3,128","price_per_share":9.51,"price_display":"9.51","price_state":"stated","total_value":29747.28,"total_display":"29,747.28","total_whole":"29,747","shares_owned_after":16624.0,"shares_owned_after_display":"16,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-09","scope":"insider"},{"id":8212178,"accession":"0001694665-23-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001694665-23-000080","line_url":"/filing/0001694665-23-000080#line-1","is_derivative":false,"issuer_cik":"0001694665","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001694665","owner_cik":"0001738885","owner_name":"Bodmer Mark","owner_display_name":"Bodmer Mark","owner_url":"/insider/0001738885","role":"Officer (CSO, President of R&D)","role_mark":"O","role_mark_label":"Officer (CSO, President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22571.0,"shares_display":"22,571","price_per_share":0.1418,"price_display":"0.14","price_state":"stated","total_value":3200.5678,"total_display":"3,200.57","total_whole":"3,201","shares_owned_after":262557.0,"shares_owned_after_display":"262,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-06-12","scope":"insider"},{"id":8594370,"accession":"0001694665-23-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001694665-23-000053","line_url":"/filing/0001694665-23-000053#line-1","is_derivative":false,"issuer_cik":"0001694665","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001694665","owner_cik":"0001738885","owner_name":"Bodmer Mark","owner_display_name":"Bodmer Mark","owner_url":"/insider/0001738885","role":"Officer (CSO, President of R&D)","role_mark":"O","role_mark_label":"Officer (CSO, President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68014.0,"shares_display":"68,014","price_per_share":0.1255,"price_display":"0.13","price_state":"stated","total_value":8535.757,"total_display":"8,535.76","total_whole":"8,536","shares_owned_after":285128.0,"shares_owned_after_display":"285,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-08","filed_date":"2023-05-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001694665","name":"Evelo Biosciences, Inc.","url":"/issuer/0001694665","role":"Officer (CSO, President of R&D)","n_filings":5,"first_seen":"2023-05-10","last_seen":"2023-11-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001738885","retrieved_at":"2026-08-27T06:15:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}